Sox17 Regulates Liver Lipid Metabolism and Adaptation to Fasting
-
- Hervé Guillou
- editor
書誌事項
- 公開日
- 2014-08-20
- 資源種別
- journal article
- 権利情報
-
- http://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.1371/journal.pone.0104925
- 公開者
- Public Library of Science (PLoS)
説明
Liver is a major regulator of lipid metabolism and adaptation to fasting, a process involving PPARalpha activation. We recently showed that the Vnn1 gene is a PPARalpha target gene in liver and that release of the Vanin-1 pantetheinase in serum is a biomarker of PPARalpha activation. Here we set up a screen to identify new regulators of adaptation to fasting using the serum Vanin-1 as a marker of PPARalpha activation. Mutagenized mice were screened for low serum Vanin-1 expression. Functional interactions with PPARalpha were investigated by combining transcriptomic, biochemical and metabolic approaches. We characterized a new mutant mouse in which hepatic and serum expression of Vanin-1 is depressed. This mouse carries a mutation in the HMG domain of the Sox17 transcription factor. Mutant mice display a metabolic phenotype featuring lipid abnormalities and inefficient adaptation to fasting. Upon fasting, a fraction of the PPARα-driven transcriptional program is no longer induced and associated with impaired fatty acid oxidation. The transcriptional phenotype is partially observed in heterozygous Sox17+/- mice. In mutant mice, the fasting phenotype but not all transcriptomic signature is rescued by the administration of the PPARalpha agonist fenofibrate. These results identify a novel role for Sox17 in adult liver as a modulator of the metabolic adaptation to fasting.
収録刊行物
-
- PLoS ONE
-
PLoS ONE 9 (8), e104925-, 2014-08-20
Public Library of Science (PLoS)
